Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia

Harapan, Harapan; Wagner, Abram L.; Yufika, Amanda; Winardi, Wira; Anwar, Samsul; Gan, Alex Kurniawan; Setiawan, Abdul Malik; Rajamoorthy, Yogambigai; Sofyan, Hizir; Mudatsir, Mudatsir

doi:10.3389/fpubh.2020.00381

Cited by 578 publications

(742 citation statements)

References 44 publications

Supporting

Mentioning

558

Contrasting

Unclassified

Order By: Relevance

“…An online survey of the French population (conducted 10 days after the nationwide lockdown was introduced in March) found that 74% would use a vaccine [8]. A similar acceptance rate was reported in other surveys (conducted around March-April) of residents in the United States (67%-69%) [9,10], Indonesia (67% to 95% depending on the effectiveness of the vaccine) [11] and 73% for parts of Europe (Denmark, France, Germany, Italy, Portugal, the Netherlands, and the UK) [12]. The difference in acceptance rate documented in this study may be due to a single or combination of factor(s) including: (1) the variation in the wording of the question; (2) high level of confidence and trust in the Australian government [6] or (3) due to concerns about increasing local transmission which were high at the time.…”

Section: Discussionsupporting

confidence: 66%

Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine

Seale

Heywood

Leask

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: There is an indication that vaccine(s) for COVID-19 could be available by early 2021. As immunisation program launches have previously demonstrated, it is essential that careful planning occurs now to ensure the readiness of the public for a COVID-19 vaccine. As part of that process, this study aimed to understand the public perceptions regarding a future COVID-19 vaccine in Australia. Methods: A national cross-sectional online survey of 1420 Australian adults (18 years and older) was undertaken between 18 and 24 March 2020. The statistical analysis of the data included univariate and multivariate logistic regression analysis. Results: Participants generally held positive views towards vaccination. Eighty percent (n=1143) agreed with the statement that getting myself vaccinated for COVID-19 would be a good way to protect myself against infection. Females (614, 83%) were more likely to agree with the statement than males (529, 78%) (aOR=1.4 (95% CI: 1.1-1.8); P=0.029), while 90.9% aged 70 and above agreed compared to 76.6% aged 18-29 year old (aOR=2.3 (95% CI:1.2-4.1); 0.008). Agreement was also higher for those with a self-reported chronic disease (aOR=1.4 (95% CI: 1.1-2.0); P=0.043) and among those who held private health insurance (aOR=1.7 (95% CI: 1.3-2.3); P<0.001). Beyond individual perceptions, 78% stated that their decision to vaccinate would be supported by family and friends Conclusion: This study presents an early indication of public perceptions towards a future COVID-19 vaccine and represents a starting point for mapping vaccine perceptions. To support an effective launch of these new vaccines, governments need to use this time to understand the communities concerns and to identify the strategies that will support engagement.

show abstract

Section: Discussionsupporting

confidence: 66%

Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine

Seale

Heywood

Leask

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…A study in Indonesia also reported that for a 95% effective COVID-19 vaccine, 93.3% would take it. 25 Another study in Malaysia revealed that 94.3% of the respondents will take COVID-19 vaccine. 26 Finding from our study also revealed that geographical location and acceptance of the COVID-19 vaccine are significantly associated.…”

Section: Discussionmentioning

confidence: 99%

When it is available, will we take it? Public perception of hypothetical COVID-19 vaccine in Nigeria

Adebisi

Alaran

Bolarinwa

et al. 2020

Preprint

View full text Add to dashboard Cite

COVID-19 pandemic is a global public health threat facing mankind. There is no specific antiviral treatment for COVID-19, and no vaccine is currently available. This study aims to understand the perception of the public towards hypothetical COVID-19 vaccine in Nigeria. We conducted a cross-sectional survey in August 2020 across the 36 states of Nigeria using an online questionnaire. The questionnaire includes sections on the demographic characteristics of the respondents and their perception regarding hypothetical COVID-19 vaccine. A total of 517 respondents completed and returned the informed consent along with the questionnaire electronically. Data were coded and abstracted into the Microsoft Excel spreadsheet and loaded into the STATA 14 software for final analysis. The results showed that more than half of the respondents were male 294 (56.87%). Most of the respondents (385, 74.47%) intend to take the COVID-19 vaccine when it becomes available. Among the 132 respondents that would not take the COVID-19 vaccine, the major reason for non-acceptance is unreliability of the clinical trials 49 (37.12%), followed by the belief that their immune system is sufficient to combat the virus 36 (27.27%). There are significant association with the respondents age and having reservations toward vaccination [χ2= 19.0389 P-value=0.00] and COVID-19 vaccine acceptance [χ2=24.3316 P-value=0.00]. Furthermore, geographical location and acceptance of the COVID-19 vaccine [χ2=13.7786 P-value=0.02] are significantly associated. Even though the majority of our respondents are willing to take the COVID-19 vaccine, our findings reiterate the need to reassure the public that any vaccine which becomes available is safe and effective.

show abstract

“…The response required for dependent variables was either "YES" or "NO" 1. Vaccine acceptance: the question asked was developed in line with Harapan et al (9) (11) however, it was modi ed to suit our study design. The question was "If the government of Uganda is to provide free COVID-19 vaccine, would you accept to be vaccinated?…”

mentioning

confidence: 99%

“…2. Vaccine trial acceptance: the questions asked here were developed according to Harapan et al (9) and it was modi ed to suit our study design. The questions were "Have you ever participated in any vaccine trial before?"…”

mentioning

confidence: 99%

Acceptance and Risk Perception of COVID-19 Vaccine in Uganda: A Cross Sectional Study in Western Uganda

Echoru¹,

Ajambo²,

Bukenya³

2020

Preprint

View full text Add to dashboard Cite

Background: Many countries have drawn their attention on developing Corona virus disease 2019 vaccine however there is less emphasis on whether this vaccine could be accepted in most of these countries. This study aimed to investigate acceptance and risk perception of COVID-19 vaccine in Uganda. Method: A simplified snowball sampling technique was used to select 1067 respondents of 18-70 years in western Uganda using an online questionnaire from July to September 2020. Vaccine acceptability and risk perception was assessed using odds ratio at 95% confidence interval using R software version 3.6.3. Results: The acceptance rate for vaccination against COVID-19 was (53.6%; 572/1067) with participants in the reference age group 18-20 (OR: 1; 95%CI: NA); males (OR: 2.1; 95%CI: 1.56-2.71; P=0.000); tertiary level of education (OR: 2.8; 95%CI: 1.25-6.11; P=0.009); students (OR: 3.19; 95%CI: 1.98-5.15; P=0.000) and non-salary earners (OR: 2.29; 95%CI: 1.53-3.44; P=0.000) significantly more likely to accept the vaccine. Results also showed that (46.4%; 495/1067) of the respondents were un-likely to accept the vaccine. About (44.6%; 476/1067) of the respondents were likely to accept vaccine clinical trials with participants in the reference age group 18-20 (OR: 1; 95%CI: NA), students (OR: 2.37; 95%CI: 1.49-3.77; P=0.000), marrieds (OR: 1.3; 95%CI: 1.03-1.69; P=0.028), and non-salary (OR: 1.56; 95%CI: 1.05-2.30; P=0.029) significantly more likely to accept clinical trials. There were (46.7%; 500/1067) of the respondents who perceived the vaccine as being risky with males (OR: 3.13; 95%CI: 2.33-4.21; P=0.000); students (OR: 2.59; 95%CI: 1.63-4.13; P=0.000); Civil servants (OR: 1.49; 95%CI: 0.98-2.25; P=0.063); and non-salary earners; (OR: 2.34; 95%CI: 1.57-3.47; P=0.000) who significantly perceived the vaccine as being more risky.Conclusion: The level of vaccine acceptance (53.6%) and risk perception (46.7%) was relatively average in western Uganda. In order to ensure successful vaccination process, the government needs to prioritize vaccine acceptance strategies especially among the risky group in the community.

show abstract

Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia

Cited by 578 publications

References 44 publications

Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine

Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine

When it is available, will we take it? Public perception of hypothetical COVID-19 vaccine in Nigeria

Acceptance and Risk Perception of COVID-19 Vaccine in Uganda: A Cross Sectional Study in Western Uganda

Contact Info

Product

Resources

About